Association of mutation and low expression of the CTCF gene with breast cancer progression-Reference-Cited by-同舟云学术

Association of mutation and low expression of the CTCF gene with breast cancer progression

Published:2020-05 Issue:5 Volume:28 Page:607-614
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Akhtar Md. Salman,Akhter Naseem,Najm Mohammad Zeeshan,Deo S.V.S,Shukla N.K.,Almalki Shaia Saleh R.,Alharbi Raed A.,Sindi Abdulmajeed Abdulghani A.,Alruwetei Abdulmohsen,Ahmad Abrar,Husain Syed Akhtar

Funder

ICMR

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference59 articles.

1. CTCF gene mutations in invasive ductal breast cancer;Aulmann;Breast Cancer Res. Treat.,2003

2. Barbareschi, M., Caffo, O., Veronese, S., Leek, R.D., Fina, P., Fox, S., Bonzanini, M., Girlando, S., Morelli, L., Eccher, C., Pezzella, F., Doglioni, C., Dalla Palma, P., Harris, A., 1996. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum. Pathol., 27, 1149–1155.

3. Identification of a novel CTCF mutation responsible for syndromic intellectual disability - a case report;Bastaki;BMC Med. Genet.,2017

4. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene;Bell;Nature,2000

5. CANCER GENOME ATLAS, N., 2012. Comprehensive molecular portraits of human breast tumours. Nature, 490, 61–70.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA fragility at topologically associated domain boundaries is promoted by alternative DNA secondary structure and topoisomerase II activity;Nucleic Acids Research;2024-03-07

2. Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review);Experimental and Therapeutic Medicine;2024-02-20

3. Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression;Oncotarget;2023-05-26

4. DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective;Cancers;2022-08-06

5. Mutations in Noncoding Cis-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer;Molecular Cancer Research;2021-09-23